Altered Expression of CXCL13 and CXCR5 in Intractable Temporal Lobe Epilepsy Patients and Pilocarpine-Induced Epileptic Rats

[1]  J. Maguire.  Epileptogenesis: More than Just the Latent Period , 2016, Epilepsy currents.

[2]  M. Verbeek,et al.  Has CXCL13 an added value in diagnosis of neurosyphilis? , 2015, Journal of clinical microbiology.

[3]  K. Rostásy,et al.  Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response. , 2015, JAMA neurology.

[4]  S. Dedeurwaerdere,et al.  Imaging brain inflammation in epilepsy , 2014, Neuroscience.

[5]  J. Puustinen,et al.  CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation , 2014, Journal of Neuroinflammation.

[6]  G. Nunnari,et al.  Targeting inflammation as a therapeutic strategy for drug-resistant epilepsies , 2014, Human vaccines & immunotherapeutics.

[7]  B. Baune,et al.  Knockout of CXCR5 increases the population of immature neural cells and decreases proliferation in the hippocampal dentate gyrus , 2014, Journal of Neuroinflammation.

[8]  R. Dingledine,et al.  The role of inflammation in epileptogenesis , 2013, Neuropharmacology.

[9]  L. Piccio,et al.  CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions , 2013, Multiple sclerosis.

[10]  A. A. Kan,et al.  Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokines , 2012, Journal of Neuroinflammation.

[11]  N. Kyritsis,et al.  The chemokine receptor cxcr5 regulates the regenerative neurogenesis response in the adult zebrafish brain , 2012, Neural Development.

[12]  S. Cepok,et al.  CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation , 2012, Journal of Neuroinflammation.

[13]  N. Esen,et al.  The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system , 2010, Brain, Behavior, and Immunity.

[14]  P. Bramanti,et al.  The emerging role for chemokines in epilepsy , 2010, Journal of Neuroimmunology.

[15]  Antonio Osculati,et al.  A role for leukocyte-endothelial adhesion mechanisms in epilepsy , 2008, Nature Medicine.

[16]  Giuseppe Biagini,et al.  The pilocarpine model of temporal lobe epilepsy , 2008, Journal of Neuroscience Methods.

[17]  C. Limatola,et al.  Activity of Adenosine Receptors Type 1 Is Required for CX3CL1-Mediated Neuroprotection and Neuromodulation in Hippocampal Neurons1 , 2008, The Journal of Immunology.

[18]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[19]  J. Nahon,et al.  Multiple actions of the chemokine stromal cell-derived factor-1alpha on neuronal activity. , 2007, Journal of molecular endocrinology.

[20]  John S Duncan,et al.  Adult epilepsy , 2006, The Lancet.

[21]  R. Ransohoff,et al.  Chemokines and chemokine receptors in inflammation of the CNS , 2005, Expert review of clinical immunology.

[22]  J. Velíšková,et al.  Inflammatory Response and Glia Activation in Developing Rat Hippocampus after Status Epilepticus , 2005, Epilepsia.

[23]  K. Krause,et al.  Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases , 2005, Brain Research Reviews.

[24]  A. Vezzani.  Inflammation and Epilepsy , 2005, Epilepsy currents.

[25]  A. Nehlig,et al.  Temporal patterns of the cerebral inflammatory response in the rat lithium–pilocarpine model of temporal lobe epilepsy , 2004, Neurobiology of Disease.

[26]  P. Loetscher,et al.  CXCR5(+) T cells: follicular homing takes center stage in T-helper-cell responses. , 2002, Trends in immunology.

[27]  M. Baggiolini,et al.  B Cell–attracting Chemokine 1, a Human CXC Chemokine Expressed in Lymphoid Tissues, Selectively Attracts B Lymphocytes via BLR1/CXCR5 , 1998, The Journal of experimental medicine.

[28]  R. Racine,et al.  Afterdischarge Thresholds and Kindling Rates in Dorsal and Ventral Hippocampus and Dentate Gyrus , 1977, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[29]  D. Tousoulis,et al.  The Role of Inflammation , 2018 .

[30]  A. Huber,et al.  Targeting CXCL13 During Neuroinflammation. , 2015, Advances in neuroimmune biology.

[31]  Tallie Z. Baram,et al.  The role of inflammation in epilepsy , 2011, Nature Reviews Neurology.